Our Areas of Focus
CureGene focuses on two major therapeutic areas: cardio-cerebrovascular and antivirals.
Our mission is to develop state-of-the-art medications that address unmet medical needs and remain competitive in the global market.
News
-
Unveils Groundbreaking Preclinical Data for CG-0416, a Novel Oral Non-GLP-1 Therapy, at ObesityWeek 2025
-
Two Key Research Findings from CureGene’s HBV Pipeline Candidate, CG-1999, Selected for ‘Poster of Distinction’ at The Liver Meeting? (AASLD 2025)
-
CureGene Publishes Research Findings in European Journal of Medicinal Chemistry